- Home
- SRPT vs VOR Comparison
SRPT vs VOR Comparison
Compare SRPT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- VOR
- Stock Information
- Founded
- SRPT 1980
- VOR 2015
- Country
- SRPT United States
- VOR United States
- Employees
- SRPT N/A
- VOR N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- VOR Health Care
- Exchange
- SRPT Nasdaq
- VOR Nasdaq
- Market Cap
- SRPT 12.2B
- VOR 57.1M
- IPO Year
- SRPT 1997
- VOR 2021
- Fundamental
- Price
- SRPT $125.39
- VOR $0.98
- Analyst Decision
- SRPT Buy
- VOR Strong Buy
- Analyst Count
- SRPT 22
- VOR 7
- Target Price
- SRPT $176.18
- VOR $11.36
- AVG Volume (30 Days)
- SRPT 1.2M
- VOR 573.4K
- Earning Date
- SRPT 11-06-2024
- VOR 11-07-2024
- Dividend Yield
- SRPT N/A
- VOR N/A
- EPS Growth
- SRPT N/A
- VOR N/A
- EPS
- SRPT 1.22
- VOR N/A
- Revenue
- SRPT $1,640,348,000.00
- VOR N/A
- Revenue This Year
- SRPT $50.40
- VOR N/A
- Revenue Next Year
- SRPT $71.44
- VOR N/A
- P/E Ratio
- SRPT $102.79
- VOR N/A
- Revenue Growth
- SRPT 48.45
- VOR N/A
- 52 Week Low
- SRPT $87.00
- VOR $0.63
- 52 Week High
- SRPT $173.25
- VOR $3.14
- Technical
- Relative Strength Index (RSI)
- SRPT 52.60
- VOR 60.38
- Support Level
- SRPT $124.42
- VOR $0.80
- Resistance Level
- SRPT $131.31
- VOR $1.10
- Average True Range (ATR)
- SRPT 4.92
- VOR 0.08
- MACD
- SRPT 0.73
- VOR 0.02
- Stochastic Oscillator
- SRPT 54.94
- VOR 65.26
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.